Landiolol, an ultra-short acting beta-1 blocker, for preventing postoperative lung cancer recurrence: study protocol for a phase III, multicenter randomized trial with two parallel groups of patients

BACKGROUND: Recurrence of cancer after curative surgery is a major problem after most cancer treatments. Increased sympathetic activity during the perioperative period could promote cancer cell invasion to blood vessels and angiogenesis, resulting in cancer metastasis. Recent studies showed that use...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Haruko, Hamasaki, Toshimitsu, Onda, Kaori, Nojiri, Takashi, Aragaki, Masato, Horie, Nao, Sato, Norihiro, Hida, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907139/
https://www.ncbi.nlm.nih.gov/pubmed/31829248
http://dx.doi.org/10.1186/s13063-019-3904-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907139/
https://www.ncbi.nlm.nih.gov/pubmed/31829248
http://dx.doi.org/10.1186/s13063-019-3904-4

Ejemplares similares